-
Entity
-
Individual
-
Location
-
C/O Credit Suisse 1 St Boston Prv Eqy, 11 Madison Avenue, New York, New York
-
Summary
-
The estimated net worth of Ronald Hunt is at least $217 K dollars as of May 17, 2024. Ronald Hunt is the Director of Iterum Therapeutics plc and owns shares of Iterum Therapeutics plc (ITRM) stock worth about $156 K. Ronald Hunt is the Director, 10%+ Owner of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. (HARP) stock worth about $32.2 K. Ronald Hunt is the Director of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $29.2 K.